Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Enlivex Ltd. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −3 vs. Q1 2022
- Shares held
- 604.7K
- −241.6K (−28.5%) vs. Q1 2022
- Total value
- $2.89M
- −$1.86M (−39.2%) vs. Q1 2022
- New holders
- 3
- 4 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Ahrens Investment Partners LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| ACG Wealth | 200 | $1.00K | 0.00% | +200 | New |
| SRS Capital Advisors, Inc. | 140 | $1.00K | 0.00% | +140 | New |
| Umb Bank N A | 550 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 400 | $2.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,215 | $5.00K | 0.00% | −4,948−80.3% | Reduced |
| Barclays PLC | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,884 | $13.0K | 0.00% | −19,685−87.2% | Reduced |
| Steward Partners Investment Advisory, LLC | 3,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 4,305 | $19.0K | 0.00% | +4,305 | New |
| Geode Capital Management, LLC | 10,420 | $47.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 12,373 | $56.0K | 0.00% | −3,241−20.8% | Reduced |
| Edmond de Rothschild Holding S.A. | 13,000 | $59.0K | 0.00% | 00.0% | Unchanged |
| ACT Capital Management, LLC | 15,000 | $68.0K | 0.10% | −10,000−40.0% | Reduced |
| UBS Group AG | 18,381 | $83.0K | 0.00% | +698+3.9% | Added |
| Susquehanna International Group Ltd. | 22,002 | $98.0K | 0.02% | −470−2.1% | Reduced |
| State Street Corp | 21,887 | $99.0K | 0.00% | +451+2.1% | Added |
| Morgan Stanley | 32,725 | $148.0K | 0.00% | +11,150+51.7% | Added |
| Compagnie Lombard Odier SCmA | 50,000 | $223.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 64,189 | $290.0K | 0.00% | +500+0.8% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 331,001 | $1.66M | 0.01% | −103,342−23.8% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −52,507−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −36,560−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −14,473−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,205−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,152−100.0% | Sold out |
| Harel Insurance Investments & Financial Services Ltd. | 0 | $0 | 0.00% | −460−100.0% | Sold out |